IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	28	23	26	18	48	81	Upgrade
Market Cap Growth	17.66%	-14.06%	46.64%	-62.80%	-40.34%	321.48%	Upgrade
Enterprise Value	27	23	25	14	37	79	Upgrade
Last Close Price	0.29	0.28	0.40	0.34	0.95	1.79	Upgrade
Forward PE	-	4.35	4.35	4.35	4.35	4.35	Upgrade
PS Ratio	25.11	17.87	19.65	19.78	122.03	90.43	Upgrade
PB Ratio	3.29	3.59	3.61	1.21	2.03	2.48	Upgrade
P/TBV Ratio	8.64	5.07	4.63	1.31	2.11	2.51	Upgrade
PEG Ratio	-	2.26	2.26	2.26	2.26	2.26	Upgrade
EV/Sales Ratio	24.22	17.71	18.91	14.82	93.57	88.35	Upgrade
Debt / Equity Ratio	0.02	0.04	0.05	0.03	0.03	0.03	Upgrade
Net Debt / Equity Ratio	-0.12	-0.03	-0.12	-0.19	-0.41	-0.41	Upgrade
Net Debt / EBITDA Ratio	0.13	0.02	0.09	0.26	0.71	1.64	Upgrade
Net Debt / FCF Ratio	0.18	0.03	0.16	0.39	1.28	1.11	Upgrade
Asset Turnover	0.11	0.14	0.10	0.04	0.01	0.03	Upgrade
Inventory Turnover	0.55	0.45	0.29	0.15	0.04	0.14	Upgrade
Quick Ratio	0.79	0.21	0.55	1.83	4.53	6.27	Upgrade
Current Ratio	1.32	1.28	1.58	3.41	6.19	9.93	Upgrade
Return on Equity (ROE)	-83.34%	-104.33%	-116.95%	-59.30%	-52.97%	-29.70%	Upgrade
Return on Assets (ROA)	-50.31%	-49.91%	-45.23%	-32.86%	-29.10%	-16.81%	Upgrade
Return on Capital Employed (ROCE)	-98.40%	-114.70%	-129.60%	-75.70%	-59.80%	-26.00%	Upgrade
Earnings Yield	-23.21%	-31.36%	-49.20%	-63.85%	-31.00%	-10.85%	Upgrade
FCF Yield	-20.26%	-21.61%	-20.20%	-40.83%	-15.89%	-15.11%	Upgrade
Buyback Yield / Dilution	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.